Back to Search
Start Over
PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION
- Source :
- HemaSphere, Vol 6, Pp 1814-1815 (2022)
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2d8f9dddd1444c099d979b8d305847f6
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/01.HS9.0000850592.82147.9b